SK281076B6 - Transdermálny dodávací systém - Google Patents
Transdermálny dodávací systém Download PDFInfo
- Publication number
- SK281076B6 SK281076B6 SK1482-96A SK148296A SK281076B6 SK 281076 B6 SK281076 B6 SK 281076B6 SK 148296 A SK148296 A SK 148296A SK 281076 B6 SK281076 B6 SK 281076B6
- Authority
- SK
- Slovakia
- Prior art keywords
- tiagabine
- ethanol
- water
- delivery system
- transdermal delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK57794 | 1994-05-20 | ||
PCT/DK1995/000194 WO1995031976A1 (en) | 1994-05-20 | 1995-05-17 | Transdermal delivery of anti-epileptic drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
SK148296A3 SK148296A3 (en) | 1997-06-04 |
SK281076B6 true SK281076B6 (sk) | 2000-11-07 |
Family
ID=8095138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1482-96A SK281076B6 (sk) | 1994-05-20 | 1995-05-17 | Transdermálny dodávací systém |
Country Status (20)
Country | Link |
---|---|
US (1) | US5750140A (hu) |
EP (1) | EP0760656A1 (hu) |
JP (1) | JPH10500415A (hu) |
KR (1) | KR970703146A (hu) |
CN (1) | CN1148806A (hu) |
AU (1) | AU698131B2 (hu) |
BR (1) | BR9507736A (hu) |
CA (1) | CA2190837C (hu) |
CZ (1) | CZ338196A3 (hu) |
FI (1) | FI964619A0 (hu) |
HU (1) | HUT75864A (hu) |
IL (1) | IL113793A (hu) |
NO (1) | NO964915D0 (hu) |
NZ (1) | NZ287012A (hu) |
PE (1) | PE2596A1 (hu) |
RU (1) | RU2152784C1 (hu) |
SK (1) | SK281076B6 (hu) |
TW (1) | TW372875B (hu) |
WO (1) | WO1995031976A1 (hu) |
ZA (1) | ZA954118B (hu) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5914333A (en) * | 1996-07-31 | 1999-06-22 | Novo Nordisk A/S | Treatment of psychotic disorders |
GB9712272D0 (en) * | 1997-06-12 | 1997-08-13 | Procter & Gamble | Cosmetic composition |
US6316010B2 (en) | 1997-06-12 | 2001-11-13 | The Procter & Gamble Company | Cosmetic compositions |
US6537537B2 (en) | 1997-06-12 | 2003-03-25 | The Procter & Gamble Company | Water-in-silicone emulsion cosmetic compositions |
GB9712271D0 (en) * | 1997-06-12 | 1997-08-13 | Procter & Gamble | Cosmetic composition |
GB9712269D0 (en) * | 1997-06-12 | 1997-08-13 | Procter & Gamble | Cosmetic composition |
IE970588A1 (en) | 1997-08-01 | 2000-08-23 | Elan Corp Plc | Controlled release pharmaceutical compositions containing tiagabine |
AU8643698A (en) * | 1997-08-01 | 1999-02-22 | Elan Corporation, Plc | Controlled release pharmaceutical compositions containing tiagabine |
FR2771292B1 (fr) * | 1997-11-21 | 2000-02-18 | Ethypharm Lab Prod Ethiques | Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques |
AU2003225813A1 (en) * | 2002-03-18 | 2003-10-08 | Roger K. Cady | Preemptive prophylaxis of migraine |
PL3474820T3 (pl) | 2017-08-24 | 2024-05-13 | Novo Nordisk A/S | Kompozycje glp-1 i ich zastosowania |
CA3165359A1 (en) | 2020-02-18 | 2021-07-22 | Dorthe Kot Engelund | Glp-1 compositions and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2105990B (en) * | 1981-08-27 | 1985-06-19 | Nitto Electric Ind Co | Adhesive skin patches |
SE8904296D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
DK58291D0 (da) * | 1991-04-02 | 1991-04-02 | Novo Nordisk As | Krystalinsk stof og dets fremstilling |
-
1995
- 1995-05-12 US US08/440,155 patent/US5750140A/en not_active Expired - Lifetime
- 1995-05-17 CZ CZ963381A patent/CZ338196A3/cs unknown
- 1995-05-17 HU HU9603206A patent/HUT75864A/hu unknown
- 1995-05-17 JP JP7529988A patent/JPH10500415A/ja active Pending
- 1995-05-17 BR BR9507736A patent/BR9507736A/pt not_active IP Right Cessation
- 1995-05-17 SK SK1482-96A patent/SK281076B6/sk unknown
- 1995-05-17 WO PCT/DK1995/000194 patent/WO1995031976A1/en not_active Application Discontinuation
- 1995-05-17 RU RU96124084/14A patent/RU2152784C1/ru active
- 1995-05-17 NZ NZ287012A patent/NZ287012A/en unknown
- 1995-05-17 CA CA002190837A patent/CA2190837C/en not_active Expired - Fee Related
- 1995-05-17 CN CN95193165A patent/CN1148806A/zh active Pending
- 1995-05-17 EP EP95919972A patent/EP0760656A1/en active Pending
- 1995-05-17 AU AU25599/95A patent/AU698131B2/en not_active Ceased
- 1995-05-19 PE PE1995269113A patent/PE2596A1/es not_active Application Discontinuation
- 1995-05-19 IL IL11379395A patent/IL113793A/xx not_active IP Right Cessation
- 1995-05-19 ZA ZA954118A patent/ZA954118B/xx unknown
- 1995-05-26 TW TW084105009A patent/TW372875B/zh active
-
1996
- 1996-11-19 FI FI964619A patent/FI964619A0/fi unknown
- 1996-11-19 NO NO964915A patent/NO964915D0/no not_active Application Discontinuation
- 1996-11-20 KR KR1019960706589A patent/KR970703146A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2190837C (en) | 2005-08-02 |
NO964915L (no) | 1996-11-19 |
BR9507736A (pt) | 1997-08-19 |
CA2190837A1 (en) | 1995-11-30 |
JPH10500415A (ja) | 1998-01-13 |
HU9603206D0 (en) | 1997-01-28 |
CZ338196A3 (en) | 1997-06-11 |
NZ287012A (en) | 1998-09-24 |
IL113793A (en) | 1999-12-31 |
ZA954118B (en) | 1996-11-19 |
HUT75864A (en) | 1997-05-28 |
RU2152784C1 (ru) | 2000-07-20 |
EP0760656A1 (en) | 1997-03-12 |
AU698131B2 (en) | 1998-10-22 |
WO1995031976A1 (en) | 1995-11-30 |
FI964619A (fi) | 1996-11-19 |
TW372875B (en) | 1999-11-01 |
AU2559995A (en) | 1995-12-18 |
IL113793A0 (en) | 1995-08-31 |
US5750140A (en) | 1998-05-12 |
NO964915D0 (no) | 1996-11-19 |
FI964619A0 (fi) | 1996-11-19 |
KR970703146A (ko) | 1997-07-03 |
SK148296A3 (en) | 1997-06-04 |
CN1148806A (zh) | 1997-04-30 |
PE2596A1 (es) | 1996-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU773778B2 (en) | Using quaternary ammonium salts for transdermal drug delivery | |
US5912271A (en) | Pharmaceutical preparation for pain management | |
US20110070213A1 (en) | Dermal compositions containing coenzyme q as the active ingredient | |
US20120309823A1 (en) | Percutaneous absorption preparations | |
JPS60161918A (ja) | メトクロプラミドの経皮投与法 | |
KR20000035800A (ko) | 침투증강제로써글리콜산지방산에스테르및이의염 | |
SK281076B6 (sk) | Transdermálny dodávací systém | |
EA030797B1 (ru) | Система трансдермальной доставки гормонов (варианты) и способы ее применения | |
US5935987A (en) | Transdermal delivery of 3,4-diarylchromans | |
EP1865931B1 (en) | Transdermal patch | |
EP0535237A1 (en) | Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same | |
CN118001256A (zh) | 氟比洛芬的外用制剂及其制备方法 | |
AU633207B2 (en) | Compositions comprising cytotoxic agent and permeation enhancers | |
JPH09503229A (ja) | エストロゲンを含む経皮的投与装置 | |
JP4885856B2 (ja) | 局所クロモリン製剤 | |
WO2017057743A1 (ja) | 経皮吸収用組成物 | |
JP3841628B2 (ja) | 経皮吸収剤 | |
WO1999024032A1 (en) | Transdermal delivery of 3,4-diarylchromans | |
CN113876740A (zh) | 一种阿戈美拉汀的透皮贴剂 | |
JP2008241245A (ja) | 関節リウマチの痛みに対する鎮痛効果を有する外用剤の薬効評価方法 | |
MXPA97005723A (en) | Transderm formulation |